Position in IBRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$19,125,200
+$350,245 QoQ
Shares Held
2,184,489
-10.8% QoQ
Ownership
0.206%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#17
of 403 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in IBRX Over Time
Shares Held
Position Value (USD)
Derivatives in IBRX
reported options exposure · as of Jun 30, 2025CallValue
$0
CallShares
0
PutValue
$52,800
PutShares
20,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. IBRX ranks #87 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in IBRX
Export CSV
33 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,125,200 | 2,184,489 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $18,774,955 | 2,447,843 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $4,717,354 | 2,382,503 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $4,070,747 | 1,654,776 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $52,800 | 20,000 | Put | Defined | 2025-08-14 | |
| 2025-06-30 | $23,116,321 | 8,756,183 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,624,324 | 539,643 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $667,476 | 260,733 | Shares | Defined | 2025-02-14 | |
| 2024-12-31 | $486,400 | 190,000 | Put | Defined | 2025-02-14 | |
| 2024-09-30 | $7,699,580 | 2,069,780 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,212,000 | 350,000 | Put | Defined | 2024-08-14 | |
| 2024-06-30 | $6,057,889 | 958,527 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $5,567,555 | 1,036,789 | Shares | Defined | 2024-05-15 | |
| 2024-03-31 | $1,423,050 | 265,000 | Put | Defined | 2024-05-15 | |
| 2024-03-31 | $10,740 | 2,000 | Call | Defined | 2024-05-15 | |
| 2023-12-31 | $4,476,910 | 891,815 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $319,133 | 188,837 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $40,588 | 14,600 | Put | Defined | 2023-08-14 | |
| 2023-06-30 | $258,725 | 93,067 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $317,635 | 174,526 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $45,630 | 9,000 | Put | Defined | 2023-02-10 | |
| 2022-12-31 | $3,867,364 | 762,794 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $1,457,947 | 293,350 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $176,955 | 47,569 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $313,580 | 55,897 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $986,100 | 162,188 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $780,513 | 80,135 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $803,820 | 56,290 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $859,671 | 36,212 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 NK | — | 19,022 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 NK | — | 17,325 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 NK | — | 16,895 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 NK | — | 30,382 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||